在子宫内膜癌中预测免疫疗法的疗效:专注于瘤微环境
Liubov A Tashireva1, Irina V Larionova1,2, Nikita A Ermak3
1Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Frontiers in immunology
|February 4, 2025
概括
免疫疗法对子宫内膜癌很有前途,但面临阻力. 了解瘤微环境和免疫相互作用是克服这种抵抗和改善患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 免疫疗法通过利用免疫系统为子宫内膜癌治疗提供了一种新的方法.
- 临床成功受到患者对免疫疗法的耐药性发展的限制.
- 抵抗机制涉及瘤细胞的改变和免疫抑制瘤微环境.
研究的目的:
- 阐明子宫内膜癌中瘤细胞,免疫系统和瘤微环境之间的复杂相互作用.
- 确定免疫检查点抑制剂耐药性的潜在机制.
- 探索潜在的生物标志物和新药,以克服免疫疗法耐药性.
主要方法:
- 对瘤微环境细胞和调节分子的累积数据的审查.
- 分析免疫检查点抑制剂治疗和耐药性的机制.
- 综合当前关于子宫内膜癌免疫治疗的知识.
主要成果:
- 瘤微环境成分显著影响免疫检查点抑制剂的有效性.
- 瘤中的遗传和表观遗传变化有助于免疫逃避.
- 识别预测生物标志物对于患者选择至关重要.
结论:
- 了解瘤微环境对于克服子宫内膜癌免疫疗法耐药性至关重要.
- 需要进一步的研究,以制定持久治疗反应的策略.
- 确定最有可能从免疫疗法中受益的患者群体是一个至关重要的未满足的需求.
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464